These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14500928)

  • 1. ESPRIT: safety and efficacy of oral anticoagulation--a rebuttal.
    ESPRIT
    Stroke; 2003 Oct; 34(10):e184. PubMed ID: 14500928
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
    ESPRIT
    Stroke; 2003 Jun; 34(6):e45-6. PubMed ID: 12730559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment: Low-dose or moderate-dose anticoagulation: dream or hope for stroke prevention?
    Hennerici MG
    Stroke; 2003 Jun; 34(6):e46-7. PubMed ID: 12750548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulation in cerebral ischemia?].
    Vennervàld K
    Ugeskr Laeger; 1997 May; 159(21):3193-4. PubMed ID: 9199015
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulants versus antiplatelet agents for acute ischemic stroke.
    Hankey GJ; Berge E; Sandercock P
    Stroke; 2003 Jun; 34(6):1571-2. PubMed ID: 12764231
    [No Abstract]   [Full Text] [Related]  

  • 7. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin or aspirin for recurrent ischemic stroke.
    Algra A;
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951857
    [No Abstract]   [Full Text] [Related]  

  • 9. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of immediate anticoagulation for ischemic stroke of presumed cardioembolic origin.
    Guedes LC; Ferro JM
    Stroke; 2008 May; 39(5):e81-2; author reply e83. PubMed ID: 18369164
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of anticoagulation control in atrial fibrillation.
    Lane DA; Lip GY
    Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin and aspirin for prevention of IHD.
    Zamorski MA
    J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990
    [No Abstract]   [Full Text] [Related]  

  • 14. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term oral anticoagulation. Self monitoring optimizes vitamin K antagonist therapy].
    MMW Fortschr Med; 2014 Nov; 156(20):79. PubMed ID: 25543379
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral anticoagulation therapy during and after coronary angioplasty.
    Ikeda U; Shimada K
    Circulation; 2001 Dec; 104(24):E150. PubMed ID: 11739325
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch Bypass Oral anticoagulants or Aspirin study). Lancet 2000; 355: 346-51.
    Anand SS
    Vasc Med; 2001; 6(1):61. PubMed ID: 11358162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.